170 related articles for article (PubMed ID: 38333211)
21. [Clinical and genetic features of MDS associated with VEXAS syndrome].
Kunimoto H
Rinsho Ketsueki; 2024; 65(4):255-264. PubMed ID: 38684436
[TBL] [Abstract][Full Text] [Related]
22. A comprehensive analysis of cytopenias and bone marrow morphology in patients with a history of bariatric and metabolic surgery.
Bruehl FK; Bosler DS; Butsch WS; Farkas DH; Ondrejka SL
Int J Lab Hematol; 2022 Apr; 44(2):263-272. PubMed ID: 34668320
[TBL] [Abstract][Full Text] [Related]
23. The relationship between idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and autoimmunity.
Barcellini W
Expert Rev Hematol; 2017 Jul; 10(7):649-657. PubMed ID: 28586251
[TBL] [Abstract][Full Text] [Related]
24. CHIP, CCUS, and Other Acronyms: Definition, Implications, and Impact on Practice.
DeZern AE; Malcovati L; Ebert BL
Am Soc Clin Oncol Educ Book; 2019 Jan; 39():400-410. PubMed ID: 31099654
[TBL] [Abstract][Full Text] [Related]
25. Capture-based targeted sequencing using a T-cell control in myeloid malignancies and idiopathic cytopenias.
Pietka G; De Lord C; Matthias G; Cheung B; Atwal S; Furtado M; Cullis J; Grey-Davies L; Narayanan S; McGregor A; Kilner M; Bosworth J; McMullin MF; Coats T; Parcharidou A; Cavenagh J; Byrne J; Iyengar S; Mohammed K; Cross N; Hubank M; Ribeiro S; Khorashad J; Wren D; O'Connor S; Taussig D
Br J Haematol; 2024 Apr; 204(4):1325-1334. PubMed ID: 38462984
[TBL] [Abstract][Full Text] [Related]
26. The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
Brett VE; Lechevalier N; Trimoreau F; Dussiau C; Dimicoli-Salazar S; Coster L; Luquet I; Nadal N; Ribourtout B; Chapiro E; Lefebvre C; Tondeur S; Balducci E; Nguyen-Khac F; Borie C; Radford-Weiss I; Barin C; Eclache V; Mansier O; Bidet A;
Genes Chromosomes Cancer; 2023 Mar; 62(3):139-151. PubMed ID: 36412977
[TBL] [Abstract][Full Text] [Related]
27. Vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome presenting as recurrent aseptic peritonitis in a patient receiving peritoneal dialysis: a case report.
Fukuda N; Kanai D; Hoshino K; Fukuda Y; Morita R; Ishikawa Y; Kanaoka T; Toya Y; Kirino Y; Wakui H; Tamura K
BMC Nephrol; 2024 Jan; 25(1):18. PubMed ID: 38212709
[TBL] [Abstract][Full Text] [Related]
28. Clonal cytopenia of undetermined significance (CCUS) with dysplasia is enriched for MDS-type molecular findings compared to CCUS without dysplasia.
Jajosky AN; Sadri N; Meyerson HJ; Oduro KA; Kelkar A; Fitzgerald B; Tomlinson B; Moore EM; Beck RC
Eur J Haematol; 2021 Apr; 106(4):500-507. PubMed ID: 33386622
[TBL] [Abstract][Full Text] [Related]
29. VEXAS Syndrome: A Case Series From a Single-Center Cohort of Italian Patients With Vasculitis.
Muratore F; Marvisi C; Castrignanò P; Nicoli D; Farnetti E; Bonanno O; Longo R; Zaldini P; Galli E; Balanda N; Beck DB; Grayson PC; Pipitone N; Boiardi L; Salvarani C
Arthritis Rheumatol; 2022 Apr; 74(4):665-670. PubMed ID: 34611997
[TBL] [Abstract][Full Text] [Related]
30. Challenges in Diagnosing Myelodysplastic Syndromes in the Era of Genetic Testing: Proceedings of the 13th Workshop of the European Bone Marrow Working Group.
Hebeda KM; Tzankov A; Boudova L; Saft L; Hasserjian RP; de Boer M; Fend F; Orazi A; Leguit R
Pathobiology; 2019; 86(1):62-75. PubMed ID: 29982244
[TBL] [Abstract][Full Text] [Related]
31. VEXAS and Myelodysplastic Syndrome: An Interdisciplinary Challenge.
Kreutzinger V; Pankow A; Boyadzhieva Z; Schneider U; Ziegeler K; Stephan LU; Kübke JC; Schröder S; Oberender C; le Coutre P; Stintzing S; Jelas I
J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398362
[TBL] [Abstract][Full Text] [Related]
32. The genetic analysis of Chinese patients with clonal cytopenias using targeted next-generation sequencing.
Zhang L; Shi Y; Chen Y; Tao S; Shi W; He Z; Chen K; Wang C; Yu L
Mol Cytogenet; 2021 Nov; 14(1):52. PubMed ID: 34794475
[TBL] [Abstract][Full Text] [Related]
33. Case report of a patient with VEXAS syndrome.
Tsourveloudis I; Georgiadi EC; Vatalis G; Kotsi P
Medicine (Baltimore); 2023 Dec; 102(52):e36738. PubMed ID: 38206689
[TBL] [Abstract][Full Text] [Related]
34. Case Report: Genetic Double Strike: VEXAS and TET2-Positive Myelodysplastic Syndrome in a Patient With Long-Standing Refractory Autoinflammatory Disease.
Lötscher F; Seitz L; Simeunovic H; Sarbu AC; Porret NA; Feldmeyer L; Borradori L; Bonadies N; Maurer B
Front Immunol; 2021; 12():800149. PubMed ID: 35126364
[TBL] [Abstract][Full Text] [Related]
35. VEXAS syndrome: Clinical manifestations, diagnosis, and treatment.
Loeza-Uribe MP; Hinojosa-Azaola A; Sánchez-Hernández BE; Crispín JC; Apodaca-Chávez E; Ferrada MA; Martín-Nares E
Reumatol Clin (Engl Ed); 2024 Jan; 20(1):47-56. PubMed ID: 38160120
[TBL] [Abstract][Full Text] [Related]
36. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
Front Immunol; 2022; 13():897722. PubMed ID: 35757758
[TBL] [Abstract][Full Text] [Related]
37. Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.
Steensma DP; Abedi M; Bejar R; Cogle CR; Foucar K; Garcia-Manero G; George TI; Grinblatt D; Komrokji R; Ma X; Maciejewski J; Pollyea DA; Savona MR; Scott B; Sekeres MA; Thompson MA; Swern AS; Nifenecker M; Sugrue MM; Erba H
BMC Cancer; 2016 Aug; 16():652. PubMed ID: 27538433
[TBL] [Abstract][Full Text] [Related]
38. The new WHO and ICC classification systems for myelodysplastic syndromes and their impact on the clinical laboratory.
Bruehl FK; Osman MM; Chen D; Dalland JC
J Hematop; 2023 Jun; 16(2):65-71. PubMed ID: 38175439
[TBL] [Abstract][Full Text] [Related]
39. Vacuoles in bone marrow progenitors: VEXAS syndrome and beyond.
Lacombe V; Hadjadj J; Georgin-Lavialle S; Lavigne C; Geneviève F; Kosmider O
Lancet Haematol; 2024 Feb; 11(2):e160-e167. PubMed ID: 38302223
[TBL] [Abstract][Full Text] [Related]
40. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
Obiorah IE; Patel BA; Groarke EM; Wang W; Trick M; Ombrello AK; Ferrada MA; Wu Z; Gutierrez-Rodrigues F; Lotter J; Wilson L; Hoffmann P; Cardona DO; Patel N; Dulau-Florea A; Kastner DL; Grayson PC; Beck DB; Young NS; Calvo KR
Blood Adv; 2021 Aug; 5(16):3203-3215. PubMed ID: 34427584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
